- Home
- ANEB vs IPA Comparison
ANEB vs IPA Comparison
Compare ANEB & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- IPA
- Stock Information
- Founded
- ANEB 2020
- IPA 1983
- Country
- ANEB United States
- IPA United States
- Employees
- ANEB N/A
- IPA N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- ANEB Health Care
- IPA Health Care
- Exchange
- ANEB Nasdaq
- IPA Nasdaq
- Market Cap
- ANEB 39.0M
- IPA 98.9M
- IPO Year
- ANEB 2021
- IPA 2017
- Fundamental
- Price
- ANEB $3.06
- IPA $1.75
- Analyst Decision
- ANEB Buy
- IPA Strong Buy
- Analyst Count
- ANEB 2
- IPA 2
- Target Price
- ANEB $8.00
- IPA $4.00
- AVG Volume (30 Days)
- ANEB 1.1M
- IPA 2.3M
- Earning Date
- ANEB 05-13-2025
- IPA 07-29-2025
- Dividend Yield
- ANEB N/A
- IPA N/A
- EPS Growth
- ANEB N/A
- IPA N/A
- EPS
- ANEB N/A
- IPA N/A
- Revenue
- ANEB N/A
- IPA $17,744,713.00
- Revenue This Year
- ANEB N/A
- IPA $4.67
- Revenue Next Year
- ANEB N/A
- IPA $14.15
- P/E Ratio
- ANEB N/A
- IPA N/A
- Revenue Growth
- ANEB N/A
- IPA 0.01
- 52 Week Low
- ANEB $0.80
- IPA $0.27
- 52 Week High
- ANEB $3.42
- IPA $2.41
- Technical
- Relative Strength Index (RSI)
- ANEB 77.51
- IPA 54.05
- Support Level
- ANEB $1.53
- IPA $1.62
- Resistance Level
- ANEB $3.42
- IPA $2.41
- Average True Range (ATR)
- ANEB 0.18
- IPA 0.29
- MACD
- ANEB 0.15
- IPA -0.04
- Stochastic Oscillator
- ANEB 80.95
- IPA 30.04
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.